-
Je něco špatně v tomto záznamu ?
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
JJ. van Dongen, L. Lhermitte, S. Böttcher, J. Almeida, VH. van der Velden, J. Flores-Montero, A. Rawstron, V. Asnafi, Q. Lécrevisse, P. Lucio, E. Mejstrikova, T. Szczepański, T. Kalina, R. de Tute, M. Brüggemann, L. Sedek, M. Cullen, AW....
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
Grantová podpora
NS10480
MZ0
CEP - Centrální evidence projektů
NT12425
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Plný text - Článek
Zdroj
Zdroj
NLK
ProQuest Central
od 2000-01-01 do Před 1 rokem
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 1997-01-01 do 2015-11-30
Nursing & Allied Health Database (ProQuest)
od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2000-01-01 do Před 1 rokem
Public Health Database (ProQuest)
od 2000-01-01 do Před 1 rokem
PubMed
22552007
DOI
10.1038/leu.2012.120
Knihovny.cz E-zdroje
- MeSH
- hematologické nádory diagnóza imunologie MeSH
- imunofenotypizace normy MeSH
- leukocyty imunologie patologie MeSH
- lidé MeSH
- monoklonální protilátky diagnostické užití MeSH
- nádorové biomarkery imunologie MeSH
- prognóza MeSH
- průtoková cytometrie normy MeSH
- studie případů a kontrol MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
- Geografické názvy
- Evropa MeSH
Most consensus leukemia & lymphoma antibody panels consist of lists of markers based on expert opinions, but they have not been validated. Here we present the validated EuroFlow 8-color antibody panels for immunophenotyping of hematological malignancies. The single-tube screening panels and multi-tube classification panels fit into the EuroFlow diagnostic algorithm with entries defined by clinical and laboratory parameters. The panels were constructed in 2-7 sequential design-evaluation-redesign rounds, using novel Infinicyt software tools for multivariate data analysis. Two groups of markers are combined in each 8-color tube: (i) backbone markers to identify distinct cell populations in a sample, and (ii) markers for characterization of specific cell populations. In multi-tube panels, the backbone markers were optimally placed at the same fluorochrome position in every tube, to provide identical multidimensional localization of the target cell population(s). The characterization markers were positioned according to the diagnostic utility of the combined markers. Each proposed antibody combination was tested against reference databases of normal and malignant cells from healthy subjects and WHO-based disease entities, respectively. The EuroFlow studies resulted in validated and flexible 8-color antibody panels for multidimensional identification and characterization of normal and aberrant cells, optimally suited for immunophenotypic screening and classification of hematological malignancies.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14082865
- 003
- CZ-PrNML
- 005
- 20250108115554.0
- 007
- ta
- 008
- 141217s2012 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/leu.2012.120 $2 doi
- 035 __
- $a (PubMed)22552007
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a van Dongen, J J M
- 245 10
- $a EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes / $c JJ. van Dongen, L. Lhermitte, S. Böttcher, J. Almeida, VH. van der Velden, J. Flores-Montero, A. Rawstron, V. Asnafi, Q. Lécrevisse, P. Lucio, E. Mejstrikova, T. Szczepański, T. Kalina, R. de Tute, M. Brüggemann, L. Sedek, M. Cullen, AW. Langerak, A. Mendonça, E. Macintyre, M. Martin-Ayuso, O. Hrusak, MB. Vidriales, A. Orfao
- 520 9_
- $a Most consensus leukemia & lymphoma antibody panels consist of lists of markers based on expert opinions, but they have not been validated. Here we present the validated EuroFlow 8-color antibody panels for immunophenotyping of hematological malignancies. The single-tube screening panels and multi-tube classification panels fit into the EuroFlow diagnostic algorithm with entries defined by clinical and laboratory parameters. The panels were constructed in 2-7 sequential design-evaluation-redesign rounds, using novel Infinicyt software tools for multivariate data analysis. Two groups of markers are combined in each 8-color tube: (i) backbone markers to identify distinct cell populations in a sample, and (ii) markers for characterization of specific cell populations. In multi-tube panels, the backbone markers were optimally placed at the same fluorochrome position in every tube, to provide identical multidimensional localization of the target cell population(s). The characterization markers were positioned according to the diagnostic utility of the combined markers. Each proposed antibody combination was tested against reference databases of normal and malignant cells from healthy subjects and WHO-based disease entities, respectively. The EuroFlow studies resulted in validated and flexible 8-color antibody panels for multidimensional identification and characterization of normal and aberrant cells, optimally suited for immunophenotypic screening and classification of hematological malignancies.
- 650 _2
- $a monoklonální protilátky $x diagnostické užití $7 D000911
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a průtoková cytometrie $x normy $7 D005434
- 650 _2
- $a hematologické nádory $x diagnóza $x imunologie $7 D019337
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunofenotypizace $x normy $7 D016130
- 650 _2
- $a leukocyty $x imunologie $x patologie $7 D007962
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a nádorové biomarkery $x imunologie $7 D014408
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Lhermitte, L
- 700 1_
- $a Böttcher, Sebastian, $d 1971- $7 xx0327357
- 700 1_
- $a Almeida, J $7 gn_A_00004623
- 700 1_
- $a van der Velden, V H J
- 700 1_
- $a Flores-Montero, J
- 700 1_
- $a Rawstron, A
- 700 1_
- $a Asnafi, V $7 gn_A_00009462
- 700 1#
- $a Lécrevisse, Q
- 700 1_
- $a Lucio, P
- 700 1_
- $a Mejstříková, Ester, $d 1977- $7 xx0105223
- 700 1_
- $a Szczepański, T
- 700 1_
- $a Kalina, Tomáš, $d 1975 říjen 11.- $7 xx0060125
- 700 1_
- $a de Tute, R
- 700 1_
- $a Brüggemann, M
- 700 1_
- $a Sedek, L
- 700 1_
- $a Cullen, M
- 700 1_
- $a Langerak, A W
- 700 1_
- $a Mendonça, A
- 700 1_
- $a Macintyre, E
- 700 1_
- $a Martin-Ayuso, M
- 700 1_
- $a Hrušák, Ondřej, $d 1965- $7 xx0036691
- 700 1_
- $a Vidriales, M B
- 700 1_
- $a Orfao, A
- 773 0_
- $w MED00003138 $t Leukemia $x 1476-5551 $g Roč. 26, č. 9 (2012), s. 1908-1975
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22552007 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20141217 $b ABA008
- 991 __
- $a 20250108115550 $b ABA008
- 999 __
- $a ok $b bmc $g 1051269 $s 881971
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 26 $c 9 $d 1908-1975 $i 1476-5551 $m Leukemia $n Leukemia $x MED00003138
- GRA __
- $a NS10480 $p MZ0
- GRA __
- $a NT12425 $p MZ0
- LZP __
- $a Pubmed-20141217